Physician profile
Deeann Wong
NPI 1063514511
$1,841.22
in general payments reported to CMS, 2019-2025
13 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $40.00 · 2021: $352 · 2022: $291 · 2023: $441 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821 · Education: $71.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.49 |
| Education | $71.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $402.29 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $339.27 | 2022-2025 | Caplyta |
| Alkermes, INC. | $228.65 | 2023-2025 | Lybalvi |
| Sunovion Pharmaceuticals INC. | $171.87 | 2019-2022 | |
| Abbvie INC. | $146.00 | 2023 | Vraylar |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Idorsia Pharmaceuticals US INC | $113.91 | 2023 | Quviviq |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $93.96 | 2025 | |
| Supernus Pharmaceuticals, INC. | $75.65 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $71.49 | 2023 | |
| Allergan, INC. | $40.00 | 2020 | |
| Vanda Pharmaceuticals INC. | $17.88 | 2025 | Fanapt |
| Shire North American Group INC | $15.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deeann Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.